Wuhan Keqian Biology Co Ltd (688526) — Financial Flexibility Index
Wuhan Keqian Biology Co Ltd (688526) has a Financial Flexibility Index of 0.32x as of September 2025. Free cash flow of CN¥185.71 Million (operating CF CN¥174.36 Million minus capex CN¥11.35 Million) represents 0% of total liabilities (CN¥580.21 Million). Check Wuhan Keqian Biology Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Wuhan Keqian Biology Co Ltd Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Wuhan Keqian Biology Co Ltd across 9 annual periods. For the full cash flow conversion analysis, see Wuhan Keqian Biology Co Ltd cash flow conversion.
Annual Financial Flexibility Index for Wuhan Keqian Biology Co Ltd (2016–2024)
Year-by-year free cash flow to debt coverage for Wuhan Keqian Biology Co Ltd. Explore Wuhan Keqian Biology Co Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.90x | CN¥499.63 Million | CN¥392.68 Million | CN¥552.80 Million | ▲ +17.3% |
| 2023 | 0.77x | CN¥642.54 Million | CN¥538.03 Million | CN¥833.59 Million | ▲ +30.5% |
| 2022 | 0.59x | CN¥526.56 Million | CN¥423.71 Million | CN¥891.63 Million | ▼ -62.7% |
| 2021 | 1.59x | CN¥905.72 Million | CN¥531.27 Million | CN¥571.41 Million | ▲ +24.6% |
| 2020 | 1.27x | CN¥511.73 Million | CN¥400.14 Million | CN¥402.40 Million | ▲ +9.7% |
| 2019 | 1.16x | CN¥292.62 Million | CN¥154.89 Million | CN¥252.48 Million | ▲ +6.9% |
| 2018 | 1.08x | CN¥383.26 Million | CN¥351.83 Million | CN¥353.51 Million | ▼ -39.9% |
| 2017 | 1.80x | CN¥466.73 Million | CN¥337.61 Million | CN¥258.86 Million | ▲ +29.2% |
| 2016 | 1.40x | CN¥249.82 Million | CN¥220.69 Million | CN¥179.01 Million | — |